# EDGAR Filing Document

**Accession Number:** 0001321732
**File Stem:** 0001321732-26-000030
**Filing Date:** 2026-6
**Character Count:** 7121
**Document Hash:** e5db1770b6013ccfd2ef5893f82a10b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001321732-26-000030.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001321732-26-000030

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260618

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260622

**DATE AS OF CHANGE**: 20260622

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Penumbra Inc
- **CENTRAL INDEX KEY:** 0001321732
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37557
- **FILM NUMBER:** 261107360

**BUSINESS ADDRESS:**
- **STREET 1:** ONE PENUMBRA PLACE
- **CITY:** ALAMEDA
- **STATE:** CA
- **ZIP:** 94502
- **BUSINESS PHONE:** (510) 995-2486

**MAIL ADDRESS:**
- **STREET 1:** ONE PENUMBRA PLACE
- **CITY:** ALAMEDA
- **STATE:** CA
- **ZIP:** 94502

?xml version='1.0' encoding='ASCII'? pen-20260618

**__________________________________________________________________________________________________________________________**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_______________________________________________________________________________________________________________________________**

**FORM 8-K** 

**_______________________________________________________________________________________________________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**June 18, 2026**

**Date of Report (Date of earliest event reported)** 

**_______________________________________________________________________________________________________________________________**

**Penumbra, Inc.**

**(Exact name of registrant as specified in its charter)**

_______________________________________________________________________________________________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-37557** | **05-0605598** |
| **(State or other jurisdiction of incorporation or organization)** | **(Commission File No.)** | **(I.R.S. employer identification number)** |

---

**One Penumbra Place**

**Alameda, CA 94502**

**(Address of principal executive offices, including zip code)**

**(510) 748-3200**

**(Registrant's telephone number, including area code)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, Par value $0.001 per share | PEN | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Item 5.07.** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Submission of Matters to a Vote of Security Holders.** |

---

(a)Penumbra, Inc. ("Penumbra" or the "Company") held its Annual Meeting of Stockholders on June 18, 2026 (the "Annual Meeting"). Proxies for the Annual Meeting were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on April 22, 2026, the record date for the Annual Meeting, there were 39,331,425 shares of the Company's common stock, par value $0.001 per share, outstanding and entitled to vote, and 29,260,683 of such shares were voted in person or by proxy at the Annual Meeting on the proposals described below.

(b)At the Annual Meeting, Penumbra's stockholders voted on the following three proposals, each of which is described in more detail in the Company's <u>[Definitive Proxy Statement on Schedule 14A](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001321732/000132173226000010/pen-20260427.htm)</u> filed with the Securities and Exchange Commission on April 29, 2026. The number of votes cast with respect to each proposal was as indicated below:

1) **Election of Class II Directors**. The following nominees were elected to serve as Class II directors until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, or, if sooner, until the director's death, resignation or removal, based on the following results of voting:

---

| | | | |
|:---|:---|:---|:---|
| **Nominee** | **Votes For** | **Votes Withheld** | **Broker Non-Votes** |
| Arani Bose, M.D. | 21,137,932 | 3,772,459 | 4,350,292 |
| Bridget O'Rourke | 23,790,926 | 1,119,465 | 4,350,292 |
| Surbhi Sarna | 24,232,264 | 678,127 | 4,350,292 |

---

2) **Ratification of Selection of Independent Registered Public Accounting Firm**. The selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra for the fiscal year ending December 31, 2026 was ratified based on the following results of voting:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| 29,208,244 | 42,529 | 9,910 | N/A |

---

3) **Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers**. The compensation of the Company's named executive officers was approved, on an advisory basis, based on the following results of voting:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| 24,113,038 | 762,612 | 34,741 | 4,350,292 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **PENUMBRA, INC.** | **PENUMBRA, INC.** |
| Date: June 22, 2026 | By: | /s/ Johanna Roberts |
|  |  | Johanna Roberts |
|  |  | Executive Vice President, General Counsel and Secretary |

---